Can a New Vaccine Change the Course of Tuberculosis?
Learn about the ongoing battle against tuberculosis (TB) in 2024 and the potential impact of new vaccines on this deadly disease. Despite existing preventive measures and treatments, TB continues to afflict millions globally, with over 10 million cases and 1.3 million deaths in 2022. Explore how novel TB vaccines targeting adolescents and adults offer hope for improved efficacy, marking a significant shift in the fight against this historic health threat.
Phase 3 Clinical Trial for TB Vaccine Underway in South Africa
Phase 3 clinical trial for M72/AS01E tuberculosis vaccine begins in South Africa, offering hope for prevention of pulmonary TB in adolescents and adults. The vaccine, supported by the Gates Foundation and Wellcome, could make a significant impact in low- and middle-income countries where TB takes a heavy toll.